Dan Grandér's Group
Molecular mechanisms of action of anti-cancer drugs and role of non-coding RNA in cancer
The aim of our research is to improve conditions for the use of anti-cancer drugs in patients with cancer. The group runs two major projects: studies on the mechanisms of cell death (and resistance) induced by well-known as well as novel anti-cancer drugs and the role of non-coding RNA in cancer.
Our research aims to reverse-engineer mechanisms of tumorigenesis and tumor cell survival by using novel single-cell genomics methods to study cells from patients. Ongoing projects focus on Acute Lymphoblastic Leukemia and Pancreatic cancer